Mr. Hamed Shahbazi of Well Health reports

WELL HEALTH AND HEALWELL AI LAUNCH WELLTRUST TO EMPOWER PATIENTS AND ACCELERATE AI POWERED ETHICAL PATIENT IDENTIFICATION FOR CLINICAL RESEARCH

Well Health Technologies Corp. and Healwell AI Inc. have launched the first phase of Welltrust, a platform enabling secure, consent-driven patient identification for clinical research within Well-operated clinics in Canada.

Welltrust accelerates clinical research recruitment by enabling patients interested in clinical trials and research to consent to future outreach. By combining Well's extensive clinical footprint with Healwell's advanced AI (artificial intelligence) capabilities, Welltrust provides a scalable, privacy-preserving infrastructure that accelerates research by developing a database of individuals who are interested in participating in such research. Patients who are not interested in participating in Welltrust can safely and securely decline participation and continue receiving care at Well clinics as they had before.

Dr. Alexander Dobranowski, president of Healwell AI, commented: "Welltrust embodies our commitment to responsible and impactful AI in health care. By integrating Healwell's data and AI capabilities directly into Well's clinical environment, we are creating an advanced AI-powered ethical patient identification and research acceleration platform. This will accelerate research and patient access to potentially life-saving innovations while respecting high standards of privacy and patient autonomy."

Platform highlights:

• Secure, patient-first consent framework: Welltrust enables patients to clearly and confidently consent to their personal health information being used for specific purposes. Today, this includes providing consent to be contacted about clinical trials and participation in information review studies. As capabilities expand, future participation shall remain voluntary and compliant with privacy laws.
• AI-enabled clinical trial recruitment: The first commercial application of Welltrust leverages Healwell's Darwen AI platform to accelerate the identification and engagement of high-fit patients with chronic or complex conditions who have explicitly consented to be contacted about clinical trial opportunities. By combining Well's care delivery network with Healwell's validated AI capabilities, Welltrust will enable high-fit patient identification at scale, improving recruitment and increasing the probability of trial success.
• Robust governance and compliance: The platform includes a unified privacy, consent and data-governance layer to meet Canadian privacy and regulatory standards, enabling compliant partnerships with pharmaceutical sponsors, research organizations and clinical trial networks.
• Foundation for future research innovation: Welltrust is designed to support additional use cases as it grows, including real-world evidence generation and enhanced clinical decision support tools.

Dr. Michael Frankel, chief medical officer of Well Health, added: "This launch marks a major step forward in our mission to empower patients and improve health care outcomes through the use of technology. Welltrust allows patients to participate in research to accelerate the next generation of therapeutics and diagnostics in a safe, transparent way. Welltrust enables partners in the life sciences ecosystem to work with a scalable, consent-driven data infrastructure. We are proud to formalize this next phase of innovation through our collaboration with Healwell."

About Well Health Technologies Corp.

Well's mission is to tech enable health care providers. The company does this by developing the best technologies, services and support available, ensuring health care providers are empowered to positively impact patient outcomes. Well's comprehensive health care and digital platform includes extensive front- and back-office management software applications that help physicians run and secure their practices. Well's solutions enable more than 43,000 health care providers between the United States and Canada and power the largest owned and operated health care ecosystem in Canada with more than 240 clinics supporting primary care, specialized care and diagnostic services. In the United States, Well's solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care and mental health. Well is publicly traded on the Toronto Stock Exchange under the symbol WELL and on the OTC (over-the-counter) exchange under the symbol WHTCF.

About Healwell AI Inc.

Healwell is a health care artificial intelligence company focused on preventive care. Its mission is to improve health care and save lives through early identification and detection of disease. Using its own proprietary technology, the company is developing and commercializing advanced clinical decision support systems that can help health care providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. Healwell is executing a strategy centred on developing and acquiring technology and AI capabilities that complement the company's road map. Healwell is publicly traded on the TSX under the symbol AIDX and on the OTC exchange under the symbol HWAIF.

We seek Safe Harbor.